Pancreatic Ductal Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Ductal Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-11-13Clinical Trial Update: Hyperpolarized 13C Pyruvate MRI for Treatment Response Assessment in Pancreatic Ductal Adenocarcinoma [Phase 2]
Phase 2 clinical trial investigating hyperpolarized 13C pyruvate MRI to assess treatment response in pancreatic ductal adenocarcinoma; statu…
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Chlorambucil in Metastatic PDAC Patients Bearing a Germ Line DNA Defects Repair Mutations (SALE Trial) [Phase 2]
Phase 2 clinical trial update evaluating chlorambucil in metastatic pancreatic ductal adenocarcinoma patients with germline DNA repair mutat…
-
CLINICAL_TRIALS trial_result · 2023-07-17Clinical Trial Update: Sitagliptin Combined With Gemcitabine and Albumin-bound Paclitaxel in PDAC Patients [Phase 2]
Phase 2 clinical trial investigating sitagliptin combined with gemcitabine and albumin-bound paclitaxel in pancreatic ductal adenocarcinoma …
-
CLINICAL_TRIALS trial_result · 2023-06-13Clinical Trial Update: A Study of Rucaparib in Patients With Pancreatic Cancer and a Known Deleterious BRCA Mutation [Phase 2]
Phase 2 trial evaluating rucaparib in pancreatic cancer patients with a deleterious BRCA mutation has completed.
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) [Phase 1, Phase 2]
Phase 1/2 trial of ascorbic acid combined with nab-paclitaxel protein-bound, cisplatin, and gemcitabine in pancreatic cancer has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-02-15Clinical Trial Update: Nab-pacliatxel Plus Gemcitabine in Korean Patients With Metastatic Pancreatic Ductal Adenocarcinoma [Phase 2]
Phase 2 clinical trial update examining nab-paclitaxel plus gemcitabine in Korean patients with metastatic pancreatic ductal adenocarcinoma …
-
CLINICAL_TRIALS trial_result · 2023-01-19Clinical Trial Update: Ultrasound-enhanced Uptake of Chemotherapy in Patients With Inoperable Pancreatic Ductal Adenocarcinoma [Phase 2]
Phase 2 trial evaluating ultrasound-enhanced uptake of chemotherapy in patients with inoperable pancreatic ductal adenocarcinoma has complet…
-
CLINICAL_TRIALS trial_result · 2022-11-30Clinical Trial Update: BMS-813160 With Nivolumab and Gemcitabine and Nab-paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC) [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating BMS-813160 in combination with nivolumab, gemcitabine, and nab-paclitaxel in borderline resectable and l…
-
CLINICAL_TRIALS trial_result · 2022-11-21Clinical Trial Update: Parvovirus H-1 (ParvOryx) in Patients With Metastatic Inoperable Pancreatic Cancer [Phase 1, Phase 2]
Clinical trial update for Parvovirus H-1 (ParvOryx) in metastatic inoperable pancreatic cancer (Phase 1/2) completed.
-
CLINICAL_TRIALS trial_result · 2022-08-22Clinical Trial Update: Lenalidomide and Gemcitabine as First-line Treatment in Patients With Pancreatic Cancer [Phase 1, Phase 2]
A phase 1/2 trial evaluating lenalidomide plus gemcitabine as first-line treatment for metastatic pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2022-08-11Clinical Trial Update: Safety and Efficacy of APX005M With Gemcitabine and Nab-Paclitaxel With or Without Nivolumab in Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma [Phase 1, Phase 2]
Phase 1/2 trial assessing APX005M with gemcitabine and nab-paclitaxel, with or without nivolumab, in previously untreated metastatic pancrea…
-
CLINICAL_TRIALS trial_result · 2022-08-02Clinical Trial Update: Nalirinox Neo-pancreas RAS Mut ctDNA Study [Phase 2]
Phase 2 clinical trial update for Nalirinox in resectable pancreatic ductal adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2022-06-15Clinical Trial Update: Multi-center, Open-label, Phase 1b Clinical Trial to Evaluate the Safety, Tolerability, and Exploratory Efficacy of TEW-7197 in Combination With FOLFOX in Patients With Metastatic Pancreatic Ductal Adenocarcinoma Who Have Failed First-Line Gemcitabine and Nab-Paclitaxel [Phase 1, Phase 2]
Phase 1b/Phase 2 open-label trial evaluating TEW-7197 in combination with FOLFOX for metastatic pancreatic ductal adenocarcinoma after failu…
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: PEN-866 in Patients With Advanced Solid Malignancies [Phase 1, Phase 2]
Clinical trial update for PEN-866 across multiple phases investigating advanced solid malignancies, including endometrial adenocarcinoma and…
-
CLINICAL_TRIALS trial_result · 2022-01-04Clinical Trial Update: Trial Comparing Adjuvant Chemotherapy With Gemcitabine Versus mFolfirinox to Treat Resected Pancreatic Adenocarcinoma [Phase 3]
A Phase 3 trial comparing adjuvant chemotherapy with gemcitabine versus mFOLFIRINOX in resected pancreatic adenocarcinoma has completed enro…
-
CLINICAL_TRIALS trial_result · 2021-12-15Clinical Trial Update: Trial to Investigate Intensified Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating intensified neoadjuvant chemotherapy for locally advanced pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-11-22Clinical Trial Update: Safety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic Cancer [Phase 3]
Phase 3 trial investigating Immuncell-LC in combination with gemcitabine for resectable pancreatic ductal adenocarcinoma is currently recrui…
-
CLINICAL_TRIALS trial_result · 2021-07-02Clinical Trial Update: A Phase 2 Study of siG12D LODER in Combination With Chemotherapy in Patients With Locally Advanced Pancreatic Cancer [Phase 2]
Phase 2 study evaluating siG12D LODER in combination with chemotherapy for locally advanced pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2021-06-10Clinical Trial Update: A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma [Phase 3]
Phase 3 study investigating napabucasin plus nab-paclitaxel with gemcitabine in adult metastatic pancreatic adenocarcinoma; trial completed …
-
CLINICAL_TRIALS trial_result · 2021-04-09Clinical Trial Update: The Combination Chemotherapy of SIRIOX as First- or Second-Line Chemotherapy for Pancreatic Cancer [Phase 2]
Phase 2 trial update for SIRIOX as first- or second-line chemotherapy in pancreatic ductal carcinoma; status currently unknown.
-
CLINICAL_TRIALS trial_result · 2021-04-06Clinical Trial Update: Dose-Escalation Study Of Palbociclib + Nab-Paclitaxel In mPDAC [Phase 1]
Phase 1 dose-escalation study evaluating Palbociclib combined with nab-paclitaxel in metastatic pancreatic ductal adenocarcinoma has complet…
-
CLINICAL_TRIALS trial_result · 2021-03-22Clinical Trial Update: Study of Single Agent Idelalisib Followed by Idelalisib in Combination With Chemotherapy in Adults With Metastatic Pancreatic Ductal Adenocarcinoma [Phase 1]
A Phase 1 trial evaluating single-agent idelalisib followed by idelalisib in combination with chemotherapy in adults with metastatic pancrea…
-
CLINICAL_TRIALS trial_result · 2021-02-10Clinical Trial Update: PAXG Out in the Country [Phase 4]
Phase 4 clinical trial update for PAXG in pancreatic ductal adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Mesothelin-Targeted Immunotoxin LMB-100 Alone or in Combination With Nab-Paclitaxel in People With Previously Treated Metastatic and/or Locally Advanced Pancreatic Ductal Adenocarcinoma and Mesothelin Expressing Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluating LMB-100 alone or with nab-paclitaxel in previously treated metastatic and/or locally advanced pancreatic ductal a…
-
CLINICAL_TRIALS trial_result · 2020-12-23Clinical Trial Update: Study Evaluating NEOadjuvant Immunotherapy in Resectable PANCreatic Ductal Adenocarcinoma [Phase 2]
Phase 2 trial evaluating neoadjuvant immunotherapy in resectable pancreatic ductal adenocarcinoma was terminated with results posted.